Health news round-up: new cancer drugs, pharmacogenomics, and whether GLP-1s cause erectile dysfunction Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Gabapentinoids found to increase risk of drug toxicity Researchers found that patients taking gabapentinoids with benzodiazepines were at double the risk of being hospitalised with drug poisoning, while combining the drug with opioids has a 30% increase in risk.…
Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Dysaesthesia added to semaglutide side effects list Abnormal and unpleasant touch-based sensations are now listed as a “common” adverse reaction to Rybelsus.…
Drug–food interactions: pharmacological principles and management strategies A summary of the underlying pharmacological principles for common drug–food interactions, outlining practical management strategies that can be used with patients in clinical practice.…
London’s first drug-checking service could expand to more cities Under the drug-checking service, users can submit substances for testing and will subsequently receive “anonymous, non-judgemental chat”, alongside tailored harm reduction advice.…
GPhC writes to pharmacy teams after methotrexate dispensed with instruction to take once daily An email sent by Roz Gittins, chief pharmacy officer at the GPhC, advised pharmacy teams to supply methotrexate in line with a drug safety update published by the MHRA in September 2020.…
‘Life-threatening condition’ added to Mounjaro patient information leaflet Manufacturer of Mounjaro, Eli Lilly has added more detail to the list of the drug's 'possible side effects'.…
Mounjaro health benefits found to reverse one year after stopping drug Researchers said their findings “underscore the importance of continued obesity treatment”.…
How safe are GLP-1s? As the use of weight-loss drugs continues to increase, there has been a rise in documented side effects. But what are the serious and unwanted effects of these drugs, and is Yellow Card reporting capturing enough information?…
